Athena Neurosciences Overview
- Year Founded
-
1986
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$625M
Athena Neurosciences General Information
Contact Information
Website
www.athenaneuro.comCorporate Office
- 800 Gateway Boulevard
- San Francisco, CA 94080
- United States
Corporate Office
- 800 Gateway Boulevard
- San Francisco, CA 94080
- United States
Athena Neurosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 01-Jul-1996 | $625M | Completed | Generating Revenue | ||
| 6. IPO | 07-Nov-1991 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 11-Feb-1991 | Completed | Generating Revenue | |||
| 4. Grant | 01-Jan-1990 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series C) | 25-Apr-1988 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 01-Jan-1987 | Completed | Generating Revenue | |||
| 1. Early Stage VC (Series A) | 01-Jan-1986 | Completed | Product Development |
Athena Neurosciences Patents
Athena Neurosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-5969950-A | Enhanced heat sink attachment | Inactive | 04-Nov-1998 | ||
| US-6241969-B1 | Aerosolized mixture of corticosteroid and a high-hlb surfactant comprising a vitamin e ethoxylate | Inactive | 26-Jun-1998 | ||
| CA-2335900-A1 | Aqueous compositions containing corticosteroids for nasal and pulmonary delivery | Active | 26-Jun-1998 | ||
| CA-2335900-C | Aqueous compositions containing corticosteroids for nasal and pulmonary delivery | Inactive | 26-Jun-1998 | ||
| EP-1089715-A1 | Aqueous compositions containing corticosteroids for nasal and pulmonary delivery | Active | 26-Jun-1998 | A61K9/0078 |
Athena Neurosciences Former Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ABR Capital Partners | Real Estate | Minority | ||
| Avalon Ventures | Venture Capital | Minority | ||
| BNP Paribas | Investment Bank | Minority | ||
| CW Group | Venture Capital | Minority | ||
| Domain Associates | Venture Capital | Minority |
Athena Neurosciences FAQs
-
When was Athena Neurosciences founded?
Athena Neurosciences was founded in 1986.
-
Where is Athena Neurosciences headquartered?
Athena Neurosciences is headquartered in San Francisco, CA.
-
What industry is Athena Neurosciences in?
Athena Neurosciences’s primary industry is Drug Discovery.
-
Is Athena Neurosciences a private or public company?
Athena Neurosciences is a Private company.
-
What is the current valuation of Athena Neurosciences?
The current valuation of Athena Neurosciences is .
-
What is Athena Neurosciences’s current revenue?
The current revenue for Athena Neurosciences is .
-
How much funding has Athena Neurosciences raised over time?
Athena Neurosciences has raised $85M.
-
Who are Athena Neurosciences’s investors?
ABR Capital Partners, Avalon Ventures, BNP Paribas, CW Group, and Domain Associates are 5 of 16 investors who have invested in Athena Neurosciences.
-
When was Athena Neurosciences acquired?
Athena Neurosciences was acquired on 01-Jul-1996.
-
Who acquired Athena Neurosciences?
Athena Neurosciences was acquired by Elan (Pharmaceuticals).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process